tiprankstipranks
Trending News
More News >
Konica Minolta Inc (JP:4902)
:4902
Advertisement

Konica Minolta (4902) AI Stock Analysis

Compare
3 Followers

Top Page

JP:4902

Konica Minolta

(OTC:4902)

Select Model
Select Model
Select Model
Neutral 48 (OpenAI - 4o)
Rating:48Neutral
Price Target:
¥522.00
▼(-2.74% Downside)
Konica Minolta's overall stock score is primarily impacted by its weak financial performance, with significant challenges in profitability and cash flow. Technical analysis provides some positive signals, but valuation remains a concern due to negative earnings. The absence of earnings call and corporate events data limits further insights.

Konica Minolta (4902) vs. iShares MSCI Japan ETF (EWJ)

Konica Minolta Business Overview & Revenue Model

Company DescriptionKonica Minolta, Inc. engages in digital workplace, professional print, healthcare, and industrial businesses in Japan, the United States, Europe, China, other Asian countries, and internationally. The company develops, manufactures, and sells multi-functional peripherals, digital printing systems, and related consumables, as well as IT and printing solutions and services. It also provides healthcare systems, such as digital X-ray diagnostic imaging, diagnostic ultrasound systems, and other systems, as well as digitalization, networking, solutions, and services in the medical field; genetic diagnostic and drug discovery support services. In addition, the company offers measuring instruments; functional film displays; organic light emitting diode lighting products; industrial inkjet printheads; lenses for industrial and professional use; and imaging-IoT and visual solutions. Konica Minolta, Inc. was founded in 1873 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyKonica Minolta generates revenue through multiple streams, primarily from the sale of its products and services across its business segments. The Business Technologies segment, which includes office equipment like multifunction printers and IT services, is a significant contributor to its earnings. The company also earns from its Healthcare segment by providing diagnostic imaging solutions, such as X-ray and ultrasound systems, to medical institutions. Additionally, Konica Minolta's Industrial Business segment includes the sale of optical devices and measuring instruments. The company leverages strategic partnerships and acquisitions to expand its market presence and enhance its technological capabilities, which further contribute to its revenue growth.

Konica Minolta Financial Statement Overview

Summary
Konica Minolta's financial performance is struggling with profitability issues. The company has seen a decline in gross profit margin and reported a negative net profit margin, highlighting financial distress. While there is some stability in the equity ratio, the high debt-to-equity ratio and negative return on equity are concerning. The mixed cash flow signals show some resilience, but operational inefficiencies need to be addressed.
Income Statement
45
Neutral
Konica Minolta's income statement reveals challenges with profitability. The gross profit margin has been declining, and the company reported a negative net profit margin in the latest fiscal year, indicating losses. Although revenue growth was seen in earlier years, recent periods have shown a decline. The negative EBIT and EBITDA margins highlight operational inefficiencies and financial distress.
Balance Sheet
50
Neutral
The balance sheet shows a moderate financial position. The debt-to-equity ratio indicates a high level of leverage, suggesting potential risk if earnings do not improve. However, the equity ratio is above average, which provides some stability. Return on equity has been negative, aligning with the company's recent losses.
Cash Flow
40
Negative
The cash flow statement presents mixed signals. While operating cash flows remain positive, free cash flow has been inconsistent, with recent improvements. The operating cash flow to net income ratio is high due to negative net income, complicating profitability assessment. The ability to generate cash flow is crucial for financial stability.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.09T1.13T1.16T1.13T911.43B863.38B
Gross Profit463.24B479.42B504.68B485.94B392.74B374.65B
EBITDA44.77B-60.74B106.18B-16.80B60.35B66.32B
Net Income-37.11B-47.85B4.52B-103.15B-26.12B-15.21B
Balance Sheet
Total Assets1.17T1.22T1.39T1.41T1.34T1.30T
Cash, Cash Equivalents and Short-Term Investments86.36B89.90B127.13B183.06B117.67B123.82B
Total Debt432.36B438.17B522.58B568.29B448.65B410.70B
Total Liabilities687.86B743.56B834.67B913.90B776.62B749.05B
Stockholders Equity466.93B463.15B539.82B487.42B549.81B539.89B
Cash Flow
Free Cash Flow2.99B25.30B38.21B-27.46B-23.61B37.86B
Operating Cash Flow47.55B51.09B83.34B13.32B37.44B78.06B
Investing Cash Flow17.57B24.65B-44.53B-37.50B-51.00B-34.33B
Financing Cash Flow-83.65B-110.90B-96.85B84.32B2.13B-13.09B

Konica Minolta Technical Analysis

Technical Analysis Sentiment
Positive
Last Price536.70
Price Trends
50DMA
517.45
Positive
100DMA
483.72
Positive
200DMA
511.57
Positive
Market Momentum
MACD
5.80
Positive
RSI
54.37
Neutral
STOCH
81.82
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4902, the sentiment is Positive. The current price of 536.7 is above the 20-day moving average (MA) of 535.59, above the 50-day MA of 517.45, and above the 200-day MA of 511.57, indicating a bullish trend. The MACD of 5.80 indicates Positive momentum. The RSI at 54.37 is Neutral, neither overbought nor oversold. The STOCH value of 81.82 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4902.

Konica Minolta Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$4.54T17.907.61%1.72%4.83%1.58%
76
Outperform
€666.05B17.759.53%2.32%6.92%16.87%
72
Outperform
¥655.32B13.117.32%3.90%4.50%56.65%
69
Neutral
¥766.54B16.294.52%2.90%6.09%16.14%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
48
Neutral
$271.45B-16.55%0.93%-7.37%-653.50%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4902
Konica Minolta
536.70
60.93
12.81%
JP:7752
RICOH CO
1,372.50
-251.70
-15.50%
JP:6448
Brother Industries
2,565.00
-294.81
-10.31%
JP:4901
FUJIFILM Holdings
3,673.00
-28.91
-0.78%
JP:8060
Canon Marketing Japan Inc.
6,032.00
1,387.04
29.86%

Konica Minolta Corporate Events

Konica Minolta’s Strategic Shift Boosts Profitability Despite Revenue Decline
Jul 31, 2025

Konica Minolta reported a decline in revenue by 8.2% for the three months ending June 30, 2025, compared to the same period last year, yet achieved a significant turnaround in profitability with a 411% increase in business contribution profit and a notable operating profit. This financial performance reflects the company’s strategic shift, including the discontinuation of its Precision Medicine Business, which has streamlined operations and improved profitability, signaling a positive outlook for stakeholders.

The most recent analyst rating on (JP:4902) stock is a Hold with a Yen500.00 price target. To see the full list of analyst forecasts on Konica Minolta stock, see the JP:4902 Stock Forecast page.

Konica Minolta Finalizes Subsidiary Share Transfer
Jun 30, 2025

Konica Minolta has completed the transfer of shares of its subsidiary, Konica Minolta Marketing Services Holding Company Limited, to adm Group LIMITED. This change, effective June 30, 2025, results in the exclusion of the subsidiary from Konica Minolta’s consolidated financial statements, with minimal impact expected on the company’s financial results for the fiscal year ending March 31, 2026.

The most recent analyst rating on (JP:4902) stock is a Hold with a Yen500.00 price target. To see the full list of analyst forecasts on Konica Minolta stock, see the JP:4902 Stock Forecast page.

Konica Minolta Reports Decline in Profitability for Fiscal Year 2025
May 15, 2025

Konica Minolta reported its consolidated financial results for the fiscal year ending March 31, 2025, showing a slight increase in revenue but a significant decline in operating profit and overall profitability compared to the previous year. The company has classified its Precision Medicine Business as a discontinued operation, impacting its financial metrics. The results indicate challenges in maintaining profitability, with a notable decrease in total assets and equity, and a negative cash flow from financing activities, which may affect stakeholders’ confidence.

The most recent analyst rating on (JP:4902) stock is a Buy with a Yen750.00 price target. To see the full list of analyst forecasts on Konica Minolta stock, see the JP:4902 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 04, 2025